Sunshine Insurance Group

Sunshine Insurance Group Company Limited is a prominent insurance provider based in Beijing, China, engaged in various segments of the insurance industry. The company primarily operates through three divisions: the life insurance segment, which offers a diverse array of life insurance products primarily under the Sunshine Life brand; the property and casualty insurance segment, which is the largest contributor to its revenue and encompasses a wide range of products offered by Sunshine P&C and Sunshine Surety; and the other businesses segment, which focuses on corporate management and asset management services. Additionally, the Sunshine Insurance Fund I, managed by the group, targets the insurance sector for investment opportunities. Through these operations, Sunshine Insurance Group aims to deliver comprehensive insurance solutions to its clients.

Rong He

Managing Director

Zhang Weigong

Founder

25 past transactions

Bang Er Orthopedic

Venture Round in 2023
Zhejiang Bang Er Medical Investment Management Co., Ltd. is a prominent operator of hospitals specializing in orthopedic care and rehabilitation services, established in 2012 in Zhejiang Province, China. The company focuses on the diagnosis and treatment of various orthopedic conditions, including trauma-related injuries, hand and foot surgery, spine surgery, and joint surgery. By offering a comprehensive range of services, Bang Er aims to provide patients with the necessary care and treatment options for their orthopedic ailments, positioning itself as a key player in the healthcare sector of the Yangtze River Delta.

Data Grand

Series C in 2022
Data Grand specializes in text processing technology and intelligent office robot services, offering a range of solutions aimed at enhancing business efficiency across various industries. Their services include a text mining engine, intelligent recommendation systems, knowledge graphs, smart document reviews, and advanced search systems. Additionally, Data Grand provides tools for customer opinion insights, optical character recognition, and robotic process automation. By employing cutting-edge technologies such as natural language understanding and generation, the company enables users to efficiently extract, review, and search information from extensive databases. This focus on intelligent software systems helps enterprises improve their data mining capabilities while ensuring compliance and safety.

Grit Science

Series A in 2022
Grit Science is a biotechnology company specializing in gene therapeutics, particularly focusing on the research and development of liver-related genes. The firm is dedicated to creating medical products and genetic treatments that address clinical needs and enhance human health. Through its innovative approach to biopharmaceutical technology, Grit Science aims to contribute significantly to the field of medicine by developing solutions that improve patient outcomes.

ChangXin Memory Technologies

Venture Round in 2022
ChangXin Memory Technologies focuses on the development and manufacture of dynamic random-access memory (DRAM) semiconductor products. The company specializes in integrated circuits designed for data memory and related functions, emphasizing low-power data storage solutions. Its activities encompass research and development, design, production, and sales of these integrated circuits, catering to various industry users.

Zaihui

Series D in 2022
Zaihui is a SaaS-based data-driven marketing automation solution for local businesses that offers them with member management, precipitation members, incentive members, and mining member values. Product system offers intelligent precision marketing, integral marketing, stored-value marketing, anniversary marketing, attendant performance, theme marketing activities, and brand packaging marketing. Zaihui is headquartered in China and the company was founded in 2015.

ImmuneOnco

Series C in 2022
ImmuneOnco Biopharma, established in June 2015 in Zhangjiang High-Tech Park, Shanghai, is an early-stage biopharmaceutical company focused on developing innovative cancer immunotherapy products. The company aims to combat cancer by reversing immune suppression caused by cancer cells and actively targeting their eradication. ImmuneOnco employs a systematic approach to leverage both the innate and adaptive immune systems, which positions it among the few biotechnology firms globally pursuing this strategy. The company has developed a diverse pipeline of 14 drug candidates, with eight currently undergoing clinical programs. This extensive portfolio underscores ImmuneOnco's deep understanding of cancer biology and immunology, as well as its capability to translate scientific research into viable therapeutic options.

XuanZhu Pharma

Series B in 2021
XuanZhu Pharma is an innovative biopharmaceutical company rooted in China, with a global perspective, focusing on tumors, metabolic diseases, infections, and other fields. It has a layout of the entire industry chain from drug discovery, preclinical research, clinical development, and production and sales.

Neurophth Therapeutics

Series C in 2021
Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.

GeekBang

Series B in 2021
GeekBang Technology operates an online learning platform designed for digital talents, focusing on immersive and in-depth learning experiences. It offers various channels, including communities, live broadcasts, and tribes, to foster engagement and knowledge sharing among users. The company provides a global IT knowledge service platform that encompasses media, conferences, training, and consulting services, all centered around technological innovation. By developing communities within the technology sector, GeekBang facilitates knowledge transfer among professionals, enhancing their skills and expertise in the field.

MabPlex

Series B in 2020
MabPlex International Ltd is a contract development and manufacturing organization specializing in biopharmaceuticals, including monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics. Founded in 2013 and headquartered in Yantai, China, with an additional office in Fremont, California, MabPlex provides a range of services from drug development to manufacturing. The company offers customized mammalian cell media, cell banking, and active pharmaceutical ingredient manufacturing, as well as biologics and ADC fill and finish services. MabPlex aims to deliver high-quality solutions for biomanufacturing, catering to partners globally.

Norson Biotechnology

Series B in 2020
Norson Biotechnology produces edible probiotic powder, probiotic solid beverages, fermented lactic acid bacteria beverages, and other products.

Huisuanzhang

Series C in 2020
Huisuanzhang is a financial services platform that caters to small and medium-sized enterprises (SMEs) in China, offering a range of services including accounting, business registration, tax audits, and trademark registration. Established in April 2015, the company has expanded its reach with seven branches across major cities such as Beijing, Shanghai, and Guangzhou, and its service network now spans over 200 cities through more than 300 regional agencies, serving over 230,000 business users. Utilizing cloud and mobile internet technology, Huisuanzhang focuses on delivering standardized and refined financial services, enhancing user experience, and addressing the specific needs of SMEs throughout their life cycle. The platform aims to provide affordable and efficient financial solutions, continuously evolving to meet the demands of its clientele in a competitive market.

Sinoiov

Series B in 2019
Beijing Sinoiov Information Technology Co., Ltd. is a data technology company focused on transforming the road freight industry through logistics technology and service platforms. By leveraging artificial intelligence and big data analysis, Sinoiov aims to help logistics customers achieve digital and intelligent transformation, ultimately reducing costs and boosting efficiency. The company has developed a comprehensive freight monitoring platform that integrates GPS tracking, intelligent dispatching systems, and cloud computing, providing vital information for optimizing freight delivery operations. With a strong presence in China, including national vehicle networking industrial bases in Beijing and Chongqing and over 40 provincial branches, Sinoiov has accumulated extensive experience in commercial vehicle networking operation management and services.

DeepWise

Series C in 2019
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.

eCheng

Series C in 2019
ECheng (e成) is a B2B SaaS platform that provides HR matching and resume screening for enterprises. Using machine learning, data mining, and NLP (natural language processing), the company categorizes resumes that best fit the job requirements of the client company. The company was launched in 2013 by industry veterans from Baidu, IBM, and Microsoft, serving multinational conglomerates as well as small and medium-sized companies.

Zhihu

Series E in 2018
Zhihu is a Chinese question-and-answer platform that distinguishes itself from traditional forums by encouraging users to share personal opinions and insights in response to inquiries. As of January 2012, the platform has amassed over 300,000 registered users. Zhihu operates primarily as an online content community and generates revenue through various channels, including paid membership services, advertising, content-commerce solutions, and vocational training. All of its revenue streams are derived from within China, reflecting its focus on the domestic market and its aim to foster a rich, interactive knowledge-sharing environment.

Meican

Series D in 2018
Meican.com is an online platform that specializes in food ordering and delivery services, catering to both individual and corporate clients. Founded in January 2011, the platform allows users to browse detailed take-out menus from over 30,000 partner restaurants in major cities such as Beijing, Shanghai, Guangzhou, and Shenzhen. Meican.com offers personalized meal selection, making it easy for users to choose their preferred dishes. Additionally, it provides enterprise solutions for efficient meal ordering, addressing challenges related to food classification and billing, thereby allowing businesses to focus on their core operations. Meican.com combines a wealth of experience in product research and development with a professional operational team, enhancing the overall food ordering experience for its users.

Carzone

Private Equity Round in 2018
Jiangsu Kangzhong Shiye Investment operates a retail chain, Carzone, that deals in and retails automotive post-market parts. The company was founded in 1995 and is based in Nanjing, China.

MEGVII

Series C in 2017
Megvii, founded in 2011, is an artificial intelligence company that specializes in intelligent solutions and data services for enterprises and developers. The company is focused on its mission to create machines capable of seeing and thinking, leveraging its deep learning system, Brain++. Megvii aims to build a comprehensive AI engine that serves as the foundational technology for various applications. It connects standardized hardware, such as sensors and personal devices, with artificial intelligence and the Internet of Things (AIoT), commercializing three main application areas: Consumer IoT, City IoT, and Supply Chain IoT. By integrating hardware and software solutions, Megvii enables clients to efficiently establish AI infrastructure tailored to their needs, positioning itself as an expert in AIoT solutions.

DoBe Group

Series B in 2017
DoBe Group, founded in 2006 and based in Shanghai, China, specializes in the development and operation of real estate properties, particularly within the cultural and creative industry sector. The company focuses on creating and managing office spaces that cater to cultural and creative enterprises, ensuring a conducive environment for their growth. In addition to real estate management, DoBe Group offers enterprise management services, brand promotion, and financial consulting to support the diverse needs of its clients. Through these services, DoBe Group aims to foster the comprehensive development of the cultural and creative industries.

Kangfu Zhijia

Series D in 2016
Kangfu Zhijia is an omni-channel service provider of household medical equipment.

QuantGroup

Series C in 2016
Founded in 2014, QuantGroup is a data-driven financial services platform that aims to enhance decision-making through independent research and technology integration. The company specializes in providing customized marketing services and financial technology solutions tailored to both consumer needs and the requirements of financial institutions. By leveraging artificial intelligence, QuantGroup offers scenario-based digital empowerment services that facilitate the digital integration of various aspects of traditional industries, including technology, operations, and local services. This approach enables clients to achieve efficient and effective solutions that enhance their operational capabilities and improve consumer experiences.

Orbiepharm

Series C in 2016
Orbiepharm is a pharmaceutical manufacturing company specializing in animal health, particularly within the veterinary industry. The company develops a range of products, including solid preparations, ointments, insecticides, inhalational anesthetics, and oral solvents, targeting various health issues in pets. Their therapeutic offerings address common, medical, chronic, and geriatric diseases. Orbiepharm stands out as a unique enterprise in China, as it integrates research and development, production, sales, and terminal hospital services, thereby enhancing the efficiency of diagnosis and treatment for animals.

Zhongguo Qiye Bao

Angel Round in 2010
Zhongguo Qiye Bao is a newspaper publishing company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.